![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, March 29, 2022 11:35:56 AM
what drug from any other microcap company has made the cover of Lancet?
Humanigen has always been different than other biotech microcaps even if the market lumps us in with companies like CYDY and RLFTF. Fortunately, government scientists/officials understand the reality and have consistently supported Humanigen. That is almost surely because Durrant and Chappell are well respected scientists who play by the rules instead of being greasy. It will pay off soon when lenz gets the EUA. It is so unbelievable that CYDY and RLFTF still have market caps higher than HGEN.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM